FeelBetter, a leading provider of medication management technology and pioneer of Pharmaco-Clinical Intelligence, has successfully secured USD 5.9 million in funding, as announced in Boston and Tel Aviv, Israel. The funding round was led by Firstime Ventures and Shoni Health Ventures, with participation from Random Forest VC, The Group Ventures, and existing investor Triventures, bringing FeelBetter’s total funding to $8 million.
The company addresses the growing public health concern of suboptimal medication management among senior patients with multiple chronic conditions. Such mismanagement leads to poor health outcomes, increased healthcare service utilization, and rising care costs. In the United States alone, this results in 275,000 deaths and more than $528 billion in avoidable costs annually.
Launched in 2018, FeelBetter is dedicated to resolving challenges associated with polypharmacy patients’ suboptimal medication management. The company’s interdisciplinary team, including clinicians, clinical pharmacists, and technologists, developed Pharmaco-Clinical Intelligence—a new category of technology. This innovative approach combines novel pharmacology and clinical capabilities, revolutionizing the polypharmacy paradigm at both individual and population health levels. Powered by AI and machine learning, FeelBetter’s Pharmaco-Clinical Intelligence enables proactive, personalized medication management to ensure patients’ regimens are safe, effective, and appropriate.
Liat Primor, CEO and Co-Founder of FeelBetter, expressed the company’s mission to deliver a personalized, holistic approach to medication management, catering to each patient’s care journey. The recent funding and the involvement of prestigious investors validate the need for FeelBetter’s solution in addressing the global health challenge of suboptimal medication management.
The funding will support FeelBetter in expanding its reach, refining its solution, and empowering more healthcare providers to deliver personalized and proactive care. FeelBetter’s Pharmaco-Clinical Intelligence matches a patient’s specific clinical and pharmacological data with their health events, allowing for precise detection of at-risk patients individually and within populations. This fosters new levels of accuracy in disease management and prevention.
FeelBetter’s Pharmaco-Clinical Intelligence synthesizes and analyzes healthcare data from various sources to identify senior patients at high risk of deterioration and preventable hospitalization due to suboptimal medication management. The software-as-a-service (SaaS) solution proactively recommends actionable interventions to reduce polypharmacy risks and enables healthcare providers to monitor patient progress and measure the impact of clinical interventions. By using FeelBetter, provider organizations can allocate resources more efficiently and effectively, reducing costly and preventable healthcare service utilization.
Michael Kerbis, Founding Partner of Random Forest VC, highlighted that FeelBetter’s algorithm draws on two decades of longitudinal clinical, pharmacy, claims, and lab data to identify patterns in complex connections between different data sources. This comprehensive approach captures the complete picture of a patient’s health journey, enabling the prediction of adverse events related to suboptimal medication regimens and timely clinical interventions for improved health outcomes.
Eran Lerer, CEO and Managing Partner of Shoni Health Ventures, praised FeelBetter’s end-to-end solution for suboptimal medication management, which includes risk stratification and adverse event prevention, allowing patients to stay safely in their communities.
We try our best to fact-check and bring the best, well-researched, and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
